GENova Biotherapeutics, Inc.
1461 A. First Avenue
Suite 360
New York
New York
10021-2209
United States
Tel: 646-845-1920
Fax: 646-514-7436
Website: http://www.genovabio.com/
22 articles about GENova Biotherapeutics, Inc.
-
GENova Biotherapeutics, Inc. Signs LOI with Korean University for Stem Cell Research and Patents Sharing
9/18/2009
-
GENova Biotherapeutics, Inc. Secures New Cancer Drugs Targets with Beckpharma
9/17/2009
-
GENova Biotherapeutics, Inc. Signs Engagement Agreement with PacificWave Partners Limited
9/16/2009
-
GENova Biotherapeutics, Inc. Signs Collaboration Agreement with Prime BioResearch
9/16/2009
-
GENova Biotherapeutics, Inc. Forming Academic Partnerships
9/16/2009
-
GENova Biotherapeutics, Inc. and TheraGlass in Advanced Negotiations
9/16/2009
-
GENova Biotherapeutics, Inc. Signs Collaboration Agreement with Bridge BioResearch
9/15/2009
-
GENova Biotherapeutics, Inc. Gains Access to Big Pharma
9/15/2009
-
GENova Biotherapeutics, Inc. Appoints Dr. Wang Chong to Scientific Advisory Board
9/15/2009
-
GENova Biotherapeutics, Inc. and Prime BioResearch Signs LOI on Diabetes and Cancer Cure
9/15/2009
-
GENova Biotherapeutics, Inc. Prepares a 510(k) Submission to the FDA
9/14/2009
-
GENova Biotherapeutics, Inc. Appoints Dr. Philip Gould to Scientific Advisory Board
9/14/2009
-
GENova Biotherapeutics, Inc.: New Stem Cell Identification Technology Could Cure Breast Cancer
9/11/2009
-
GENova Biotherapeutics, Inc. to Acquire Three New Drug Target Patents Worth in Excess of $1 Billion in Royalty Fees
9/11/2009
-
GENova Biotherapeutics, Inc. Files Patent for New Breast Cancer Treatment
9/10/2009
-
GENova Biotherapeutics, Inc. Appoints Director of Asian Business Development
9/10/2009
-
GENova Biotherapeutics, Inc. Discusses Development of New Anti-Cancer Biotechs Potentially Worth $400 Million per Annum
9/9/2009
-
GENova Biotherapeutics, Inc. Appoints Dr. Anders Boegh Jensen to Scientific Advisory Board
9/9/2009
-
GENova Biotherapeutics, Inc. Files Patent for New Prostate Cancer Treatment
9/8/2009
-
GENova Names Dr. John Savin as Vice President
9/4/2009